Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare Limited has announced the launch of two new Ayurvedic products: Acharya Ji's Jeevanodya Vati (60 Tablets) and Acharya Ji's Ojavardhan Vati (60 Tablets). Both products are targeted at the domestic market and were launched on September 5, 2026. This expansion aims to strengthen and broaden the company's portfolio in the Ayurvedic healthcare and wellness sector. Further details as required by SEBI regulations are annexed to the filing.

Jeena Sikho Lifecare Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, as required by SEBI Listing Regulations. This report is an integral part of the company's Integrated Annual Report for FY26 and is available on their website. The report highlights the company's commitment to advancing holistic healthcare through Ayurveda, expanding its network of hospitals, clinics, and day-care centers, and growing its product portfolio. Key initiatives for FY26 included digital consultations, technology-led patient engagement, and initial steps towards international expansion. The company emphasizes its mission to make holistic care more accessible and relevant, focusing on prevention and long-term well-being.

Jeena Sikho Lifecare Ltd has dispatched physical communications containing the web-link for its Integrated Annual Report for FY 2025-26 and the Notice for its 9th Annual General Meeting (AGM) to members without registered email addresses. The AGM is scheduled for September 28, 2026. The company also reminded shareholders to update KYC details, including PAN, address, and bank information, as mandated by SEBI, especially for those holding physical securities. Failure to update may restrict dividend and other payments to electronic modes.

Jeena Sikho Lifecare Limited has announced its 9th Annual General Meeting (AGM) scheduled for September 28, 2026, in Zirakpur, Punjab. The company has released its Integrated Annual Report for the Financial Year 2025-26 and the Notice of the AGM. Key resolutions include the adoption of audited standalone and consolidated financial statements, declaration of a final dividend of ₹4.50 per equity share, reappointment of directors, and approval for loans and investments under relevant sections of the Companies Act. The documents are available electronically and physically upon request, as well as on the company's website and NSDL's e-voting portal.

Jeena Sikho Lifecare Limited has announced its 9th Annual General Meeting (AGM) will be held on September 28, 2026, at 12:00 Noon in Zirakpur, Punjab. The meeting agenda includes adopting the audited financial statements for FY 2025-26, declaring a final dividend of ₹4.50 per equity share, and reappointing/appointing several directors, including key managerial personnel. The notice and annual report for FY 2025-26 have been dispatched electronically to members and are also available on the company's website and NSDL's e-voting portal.

Jeena Sikho Lifecare Ltd announced the expansion of its product portfolio with the introduction of six new Ayurvedic, healthcare, and wellness products. The new launches include Narie Xpert Granules, Syrup, and Tablets, along with Porush Xpert Granules, Syrup, and Tablets. These products are slated for a domestic market launch on September 2, 2026. This strategic move aims to broaden the company's offerings in the growing health and wellness sector.

Jeena Sikho Lifecare Limited's Board of Directors has approved the Annual Report for FY 2025-26 and fixed Monday, September 28, 2026, as the date for the 9th Annual General Meeting (AGM). The AGM will be held at 12:00 Noon at their Zirakpur, Punjab office. The company also set Monday, September 21, 2026, as the Record Date for determining eligibility for the final dividend of ₹4.50 per equity share, subject to member approval at the AGM. The Book Closure period is from September 22 to September 28, 2026. Mr. Vivek Rawal has been appointed as the Scrutinizer for the AGM.

Jeena Sikho Lifecare Limited's Board of Directors has fixed Monday, September 21, 2026, as the record date for determining shareholder eligibility for the final dividend, if declared at the upcoming 9th Annual General Meeting (AGM). The AGM is scheduled for Monday, September 28, 2026. The Board also approved the Annual Report for FY 2025-26 and appointed a scrutinizer for the AGM. The book closure for the AGM will be from September 22 to September 28, 2026, with September 21, 2026, set as the cut-off date for remote e-voting.

Jeena Sikho Lifecare Limited announced the outcome of its Board Meeting held on August 31, 2026. The board approved the Annual Report for FY 2025-26, including various supporting reports. The 9th Annual General Meeting (AGM) is scheduled for September 28, 2026. A final dividend of ₹4.50 per equity share for FY 2025-26 was recommended, subject to member approval. The record date for this dividend has been fixed as September 21, 2026. The company also appointed a scrutineer for the AGM and set the book closure period from September 22 to September 28, 2026.

Jeena Sikho Lifecare Limited has announced that its Board of Directors has fixed Monday, September 21, 2026, as the record date for determining shareholder eligibility for a final dividend. The company also approved the Annual Report for FY 2025-26, scheduled the 9th Annual General Meeting for September 28, 2026, and appointed a scrutinizer. The proposed dividend is ₹4.50 per equity share, subject to member approval at the AGM. Book closure for the AGM is set from September 22 to September 28, 2026, with September 21, 2026, also serving as the cut-off date for remote e-voting.